[go: up one dir, main page]

Sun et al., 2018 - Google Patents

Linear dextrin as curcumin delivery system: Effect of degree of polymerization on the functional stability of curcumin

Sun et al., 2018

Document ID
3678533536083371121
Author
Sun B
Tian Y
Chen L
Jin Z
Publication year
Publication venue
Food Hydrocolloids

External Links

Snippet

Linear dextrin (LD)/curcumin complexes were fabricated through co-precipitation method. The effect of reaction time, weight ratio and degree of polymerization (DP) on curcumin payload, inclusion rate, as well as the yield of complexes was investigated. For LD with DP …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48961—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the conjugate being in the form of a host-guest, i.e. being an inclusion complex, e.g. clathrate, cavitate, fullerene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles

Similar Documents

Publication Publication Date Title
Sun et al. Linear dextrin as curcumin delivery system: Effect of degree of polymerization on the functional stability of curcumin
Feng et al. Emulsion-based delivery systems for curcumin: Encapsulation and interaction mechanism between debranched starch and curcumin
Chen et al. Novel γ-cyclodextrin-metal–organic frameworks for encapsulation of curcumin with improved loading capacity, physicochemical stability and controlled release properties
Pan et al. Preparation and characterization of emulsion stabilized by octenyl succinic anhydride-modified dextrin for improving storage stability and curcumin encapsulation
Qiu et al. Resveratrol-loaded core-shell nanostructured delivery systems: Cyclodextrin-based metal-organic nanocapsules prepared by ionic gelation
Acevedo-Guevara et al. Development of native and modified banana starch nanoparticles as vehicles for curcumin
Zhi et al. Self-assembled micelles of dual-modified starch via hydroxypropylation and subsequent debranching with improved solubility and stability of curcumin
Zhang et al. Preparation, properties and interaction of curcumin loaded zein/HP-β-CD nanoparticles based on electrostatic interactions by antisolvent co-precipitation
Liang et al. Octenyl succinate anhydride debranched starch-based nanocarriers for curcumin with improved stability and antioxidant activity
Miskeen et al. Application of starch nanoparticles as host materials for encapsulation of curcumin: Effect of citric acid modification
Kamwilaisak et al. Rheology, stability, antioxidant properties, and curcumin release of oil-in-water Pickering emulsions stabilized by rice starch nanoparticles
Ranjbar et al. Carboxymethyl starch encapsulated 5-FU and DOX co-loaded layered double hydroxide for evaluation of its in vitro performance as a drug delivery agent
Xiao et al. Preparation and characterization of curcumin-loaded debranched starch/Mesona chinensis polysaccharide microcapsules: Loading levels and in vitro release
Luo et al. Preparation of starch-based drug delivery system through the self-assembly of short chain glucans and control of its release property
Sadeghi et al. Effects of starch composition and type of non-solvent on the formation of starch nanoparticles and improvement of curcumin stability in aqueous media
Chen et al. Encapsulation of luteolin using oxidized lotus root starch nanoparticles prepared by anti-solvent precipitation
Liang et al. Effect of debranching on the structure and digestibility of octenyl succinic anhydride starch nanoparticles
Letona et al. Amylosucrase‐mediated β‐carotene encapsulation in amylose microparticles
Nguyen et al. β-cyclodextrin/alginate nanoparticles encapsulated 5-fluorouracil as an effective and safe anticancer drug delivery system
Semyonov et al. Enzymatically synthesized dextran nanoparticles and their use as carriers for nutraceuticals
Li et al. Novel amphiphilic carboxymethyl curdlan-based pH responsive micelles for curcumin delivery
Zhi et al. Dual-modified starch nanospheres encapsulated with curcumin by self-assembly: Structure, physicochemical properties and anti-inflammatory activity
Omrani et al. New cyclodextrin-based supramolecular nanocapsule for codelivery of curcumin and gallic acid
Li et al. Preparation and characterization of fine and stable short amylose nanocarriers for curcumin using a highly efficient and convenient method
Hu et al. Developing DHA microcapsules using linear dextrin aggregates of different chain length distributions